Iptyx Corporation - Cambridge, Massachusetts 02142

Business Name:	Iptyx Corporation
Contact Person:	Colin Cumming
Address:	215 First St # 104, Cambridge, Massachusetts 02142
Phone Number:	No number given
Annual Revenue (USD):	$100.000 to $499.999
Location Type:	Single Location
Employee Number:	1 to 4
Business Type:	B2B (Business to Business)
Business Category:	Research and Development Laboratories
SIC Code:	8731
NAICS Code:	541712
Share This Business:
Related Businesses:	Euclides Technologies Inc - Cambridge, MA 02142 Janus Biotherapeutics Inc - Cambridge, MA 02142 Massachusetts Institute Of Technology - Cambridge, MA 02142 Panasonic Technologies Inc - Cambridge, MA 02142 Thermogen Hague Incorporated - Cambridge, MA 02142 Enernetics Inc - Cambridge, MA 02142 Bgi Americas Corp - Cambridge, MA 02142 Celexion LLC - Cambridge, MA 02142 Theracrine Inc - Cambridge, MA 02142 Alinea Pharmaceuticals - Cambridge, MA 02142 Avicena Group Inc - Cambridge, MA 02142 Aerospace Missions Corporation - Cambridge, MA 02142 Battelle Memorial Institute - Cambridge, MA 02142 Smartworlds LLC - Cambridge, MA 02142 Biogen Idec Hemophilia - Cambridge, MA 02142 Research Institute-Medicine - Cambridge, MA 02142 Verenium Corporation - Cambridge, MA 02142 Kinalco Inc - Cambridge, MA 02142 In Vivo Therapeutics Corp - Cambridge, MA 02142

The company Iptyx Corporation provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts. 1 to 4 employees work for Iptyx Corporation, and the business now earns $100.000 to $499.999 per annum.

Iptyx Corporation was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact Iptyx Corporation, please call Colin Cumming with the phone number No number given or visit its single location at 215 First St # 104 in Cambridge, Massachusetts 02142.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.